Clinical trial
Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in…
NCT02713178 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT02713178 |
|---|---|
| Title | Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL for Postsurgical Analgesia in Subjects Undergoing Total Knee Arthroplasty |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | bupivacaine liposome injectable suspension, Placebo |
| Enrollment | 232 |
| Start date | Jun 3, 2016 |
| Primary completion | Jun 30, 2017 |
| Completion | Jun 30, 2017 |
| First posted | Mar 18, 2016 |
| Last update posted | Dec 1, 2020 |
| Countries | Belgium, Denmark, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: